Lauren J. Ralph

Lauren J. Ralph

Auto-generated profile, based on publicly available information

Lauren J. Ralph

Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 1330 Broadway, Oakland, CA, 94612, United States, 1 502-938-1448

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
LRLauren Ralph
Lauren Ralph
DFDiana G. Foster
Diana G. Foster
SRSarah Raifman
Sarah Raifman
MBM. Antonia Biggs
M. Antonia Biggs
GSGoleen Samari
Goleen Samari
DGDaniel Grossman
Daniel Grossman
Self-managed abortion (SMA) is any action taken to end a pregnancy outside the formal health care system and includes self-sourcing the World Health Organization (WHO)–recommended medications (ie, mifepristone and misoprostol), ingesting herbs or other drugs, and physical methods, such as insertion of foreign objects into the uterus.1 People’s reasons for SMA are varied, and include both difficulty accessing facility-based abortion care and a preference for a more private or natural abortion experience.2-4

22 February 2011 in Sexuality Research and Social Policy
Verified
Journal Article
Open access
PDF file
LRLauren J. Ralph
Lauren J. Ralph
NBNancy F. Berglas
Nancy F. Berglas
SSSarah L. Schwartz
Sarah L. Schwartz
CBClaire D. Brindis
Claire D. Brindis
The increasing popularity and widespread use of the Internet has made it an emerging venue for delivering health-related messages and interventions. The current study explored the potential for using social networking sites (SNS), specifically MySpace, to connect youth to sexual health services. Surveys and focus groups with youth aged 14–19 living in low-income communities in California revealed high levels of overall Internet access, frequent use of SNS, and experience in searching for health information online. However, disparities in frequency and location of Internet access by race/ethnicity, and hesitancy among some youth to join a clinic’s online social network, may affect the success of this new strategy in some populations. Interviews with clinic staff highlighted the successes and challenges of using MySpace as part of their outreach efforts. Staff described balancing the benefits of web-based outreach, including its low cost, wide reach, and teen friendliness, with its challenges, including overcoming technological barriers, ensuring teens’ safety from inappropriate contact, and remaining timely and relevant given the dynamic nature of the Internet. This study indicates that SNS and other technologies have strong potential for reaching diverse youth with critical health information when implemented as part of a comprehensive outreach strategy.

20 August 2019 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
LRLauren J. Ralph
Lauren J. Ralph
ESEleanor Bimla Schwarz
Eleanor Bimla Schwarz
DGDaniel Grossman
Daniel Grossman
DFDiana Greene Foster
Diana Greene Foster
Research demonstrates worse short-term morbidity and mortality associated with childbirth than with abortion, but little research has examined long-term physical health in women with unwanted pregnancies after abortion versus childbirth. To examine the physical health of women who seek and receive or are denied abortion. Prospective cohort study. 30 U.S. abortion facilities from 2008 to 2010. Of 1132 women seeking abortion who consented to participate, 874 were included in this analysis (328 who had first-trimester abortion, 383 who had second-trimester abortion, and 163 who gave birth). Self-reported overall health; chronic abdominal, pelvic, back, and joint pain; chronic headaches or migraines; obesity; asthma; gestational and nongestational hypertension and diabetes; and hyperlipidemia were assessed semiannually for 5 years. Mortality was assessed by using verbal autopsy and public records. No significant differences were observed in self-rated health or chronic pain after first-trimester versus second-trimester abortion. At 5 years, 27% (95% CI, 21% to 34%) of women who gave birth reported fair or poor health compared with 20% (CI, 16% to 24%) of women who had first-trimester abortion and 21% (CI, 18% to 25%) who had second-trimester abortion. Women who gave birth also reported more chronic headaches or migraines and joint pain, but experienced similar levels of other types of chronic pain and obesity. Gestational hypertension was reported by 9.4% of participants who gave birth. Eight of 1132 participants died during follow-up, 2 in the postpartum period. Maternal mortality did not differ statistically by group. Self-reported outcome measures, uncertain generalizability, and 41% loss to follow-up at 5 years. Although some argue that abortion is detrimental to women's health, these study data indicate that physical health is no worse in women who sought and underwent abortion than in women who were denied abortion. Indeed, differences emerged suggesting worse health among those who gave birth. An anonymous foundation.

1 March 2017 in Contraception
Verified
Journal Article
Open access
LRLauren J. Ralph
Lauren J. Ralph
DFDiana Greene Foster
Diana Greene Foster
KKKatrina Kimport
Katrina Kimport
DTDavid Turok
David Turok
SRSarah C.M. Roberts
Sarah C.M. Roberts
Evaluating decisional certainty is an important component of medical care, including preabortion care. However, minimal research has examined how to measure certainty with reliability and validity among women seeking abortion. We examine whether the Decisional Conflict Scale (DCS), a measure widely used in other health specialties and considered the gold standard for measuring this construct, and the Taft-Baker Scale (TBS), a measure developed by abortion counselors, are valid and reliable for use with women seeking abortion and predict the decision to continue the pregnancy. Eligible women at four family planning facilities in Utah completed baseline demographic surveys and scales before their abortion information visit and follow-up interviews 3 weeks later. For each scale, we calculated mean scores and explored factors associated with high uncertainty. We evaluated internal reliability using Cronbach's alpha and assessed predictive validity by examining whether higher scale scores, indicative of decisional uncertainty or conflict, were associated with still being pregnant at follow-up. Five hundred women completed baseline surveys; two-thirds (63%) completed follow-up, at which time 11% were still pregnant. Mean scores on the DCS (15.5/100) and TBS (12.4/100) indicated low uncertainty, with acceptable reliability (α=.93 and .72, respectively). Higher scores on each scale were significantly and positively associated with still being pregnant at follow-up in both unadjusted and adjusted analyses. The DCS and TBS demonstrate acceptable reliability and validity among women seeking abortion care. Comparing scores on the DCS in this population to other studies of decision making suggests that the level of uncertainty in abortion decision making is comparable to or lower than other health decisions. The high levels of decisional certainty found in this study challenge the narrative that abortion decision making is exceptional compared to other healthcare decisions and requires additional protection such as laws mandating waiting periods, counseling and ultrasound viewing.

1 October 2010 in Current Opinion in Obstetrics and Gynecology
Verified
Journal Article
Closed access
LRLauren J Ralph
Lauren J Ralph
CBClaire D Brindis
Claire D Brindis
This review summarizes recent research on the topic of adolescents' access to reproductive healthcare, including an overview of recommended reproductive health services, access to the healthcare system and reproductive health specifically, and barriers and emerging service delivery and policy issues in the field. Recent research confirms the need for diverse healthcare points of access to the reproductive healthcare system for adolescents. It also highlights key policy and service delivery strategies that can improve access to and use of reproductive healthcare among adolescents. Access to high quality, confidential, and comprehensive reproductive healthcare is critical to ensuring the overall health of adolescents. Most adolescents are sexually active, and as a result require a wide range of counseling, clinical, and preventive care. The current healthcare system is not adequately structured to meet the diverse needs of adolescents, in particular for reproductive health needs. Continued attention to removing common barriers to care, such as concerns about confidentiality and cost, as well as promoting new screening and delivery strategies, are critical to reducing the incidence of unintended pregnancy and sexually transmitted infections among youth.

1 May 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
LRLauren J. Ralph
Lauren J. Ralph
KEKatherine Ehrenreich
Katherine Ehrenreich
RBRana Barar
Rana Barar
MBM. Antonia Biggs
M. Antonia Biggs
NMNatalie Morris
Natalie Morris
DGDaniel Grossman
Daniel Grossman
Mifepristone, used together with misoprostol, is approved by the United States Food and Drug Administration for medication abortion through 10 weeks' gestation. Although in-person ultrasound is frequently used to establish medication abortion eligibility, previous research demonstrates that people seeking abortion early in pregnancy can accurately self-assess gestational duration using the date of their last menstrual period. In this study, we establish the screening performance of a broader set of questions for self-assessment of gestational duration among a sample of people seeking abortion at a wide range of gestations. We surveyed patients seeking abortion at 7 facilities before ultrasound and compared self-assessments of gestational duration using 11 pregnancy dating questions with measurements on ultrasound. For individual pregnancy dating questions and combined questions, we established screening performance focusing on metrics of diagnostic accuracy, defined as the area under the receiver operating characteristic curve, sensitivity (or the proportion of ineligible participants who correctly screened as ineligible for medication abortion), and proportion of false negatives (ie, the proportion of all participants who erroneously screened as eligible for medication abortion). We tested for differences in sensitivity across individual and combined questions using McNemar's test, and for differences in accuracy using the area under the receiver operating curve and Sidak adjusted P values. One-quarter (25%) of 1089 participants had a gestational duration of >70 days on ultrasound. Using the date of last menstrual period alone demonstrated 83.5% sensitivity (95% confidence interval, 78.4-87.9) in identifying participants with gestational durations of >70 days on ultrasound, with an area under the receiver operating characteristic curve of 0.82 (95% confidence interval, 0.79-0.85) and a proportion of false negatives of 4.0%. A composite measure of responses to questions on number of weeks pregnant, date of last menstrual period, and date they got pregnant demonstrated 89.1% sensitivity (95% confidence interval, 84.7-92.6) and an area under the receiver operating curve of 0.86 (95% confidence interval, 0.83-0.88), with 2.7% of false negatives. A simpler question set focused on being >10 weeks or >2 months pregnant or having missed 2 or more periods had comparable sensitivity (90.7%; 95% confidence interval, 86.6-93.9) and proportion of false negatives (2.3%), but with a slightly lower area under the receiver operating curve (0.82; 95% confidence interval, 0.79-0.84). In a sample representative of people seeking abortion nationally, broadening the screening questions for assessing gestational duration beyond the date of the last menstrual period resulted in improved accuracy and sensitivity of self-assessment at the 70-day threshold for medication abortion. Ultrasound assessment for medication abortion may not be necessary, especially when requiring ultrasound could increase COVID-19 risk or healthcare costs, restrict access, or limit patient choice.